Guerrero Ramiro's Form 4 filing
MAIA Biotechnology, Inc. (MAIA) · filed Nov 4, 2024
- Accession no.
- 0001127602-24-026380
- Filed
- Nov 4, 2024
- Trade date
- Nov 1, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $222.2K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Guerrero RamiroCIK 0001913253 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | Common Stock | PPurchaseAcquired | +88,534 | $2.51 | +$222,220.34 | 408,134.04 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | Common Stock | PPurchaseAcquired | +88,534 | $2.26 | +$200,086.84 | 88,534 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.